与新型细胞免疫疗法相关的心血管毒性
Malak Munir1, Ahmed Sayed1,2, Daniel Addison3,4
1Department of Medicine, Ain Shams University Faculty of Medicine, Cairo, Egypt.
Blood advances
|October 17, 2024
概括
像CAR-T和BTE治疗这样的新型T细胞疗法是有效的,但可能导致严重的心脏问题. 了解和管理这些心血管毒性对于患者的生存至关重要.
科学领域:
- 在瘤学瘤学.
- 心脏病学 心脏病学
- 免疫治疗是一种免疫疗法.
背景情况:
- 化学抗原受体T细胞 (CAR-T) 和双特异性T细胞参与剂 (BTE) 疗法已经改变了血液恶性瘤治疗.
- 瘤透性淋巴细胞是固体瘤的新型细胞疗法.
- 这些先进疗法与严重的心血管并发症有关.
研究的目的:
- 审查与T细胞导向疗法相关的心血管毒性现有证据.
- 检查发病率,风险因素,机制和管理策略.
- 专注于CAR-T和BTE疗法及其心血管影响.
主要方法:
- 审查现有文献和关于T细胞疗法和心血管事件的报告数据.
- 分析特定的毒性,如心律失常,心力衰竭和心肌炎.
- 探索超越细胞因子释放综合征的机制.
主要成果:
- 包括CAR-T和BTE在内的T细胞疗法与严重心血管毒性的高发病率有关.
- 这些事件,包括心房动和心力衰竭,可以限制长期的生存率.
- 细胞因子释放综合征是已知的因素,但其他机制也会导致心脏毒性.
结论:
- 心血管毒性是新型T细胞疗法的一个重要问题.
- 需要进一步的研究来了解机制并优化管理.
- 解决这些毒性对于改善接受这些治疗的患者的治疗结果至关重要.
更多相关视频
09:34Dynamic Imaging of Chimeric Antigen Receptor T Cells with [18F]Tetrafluoroborate Positron Emission Tomography/Computed Tomography
Published on: February 17, 2022
3.3K
09:56A Nonviral Approach to Generate Transient Chimeric Antigen Receptor T Cells Using mRNA for Cancer Immunotherapy
Published on: February 21, 2025
464
相关概念视频
Heart Failure Drugs: Inotropic Agents
534
Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
534
Tumor Immunotherapy
488
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
488
Myocarditis I: Introduction
2
Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
2
Myocarditis III: Medical Management
2
Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
2
Cytotoxic T Cells-mediated Immune Response
857
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
857
Cardiomyopathy II: Dilated Cardiomyopathy
1
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
1
